New Target Date for ALKS Drug (Zacks.com via Yahoo! Finance)
More info…
FDA extended the review of the new drug application of exenatide once-weekly, co-developed by Alkermes, Eli Lilly and Amylin.
Drug Rehabilitation Alternatives
More info…
FDA extended the review of the new drug application of exenatide once-weekly, co-developed by Alkermes, Eli Lilly and Amylin.
Drug Rehabilitation Alternatives